Achromobacter xylosoxidans in cystic fibrosis:: Prevalence and clinical relevance
Achromobacter xylosoxidans in cystic fibrosis:: Prevalence and clinical relevance
复制标题
DOI:
10.1016/j.jcf.2006.05.011
复制
发表时间:
2007-01-01
影响因子:
5.2
通讯作者:
Vaneechoutte, Mario
中科院分区:
文献类型:
--
作者:
De Baets, Frans;Schelstraete, Petra;Vaneechoutte, Mario
Background: Achromobacter xylosoxidans is increasingly cultured in sputum from cystic fibrosis (CF) patients; nevertheless, there are few published data on the clinical impact of this infection or chronic colonisation.Methods: Relying on DNA fingerprinting techniques we studied the prevalence of A. xylosoxidans in our CF population. In a retrospective case control study the clinical status of patients with at least 3 sputum cultures positive for A. xylosoxidans over at least 9 months, at the moment of the first positive culture and during the period of colonisation were compared to age (1 year), gender and to Pseudomonas aeruginosa colonisation controlled CF patients who had never A. xylosoxidans positive sputum cultures.Results: The prevalence of patients with at least one positive A. xylosoxidans culture was 17.9%. 5.3% of the patients fulfilled the criteria of our definition of colonisation.Colonised patients had a median age of 20 years (range 11-27 years) and a mean colonisation period of 1.5 (+/- 0.9) years.At the moment of the first positive culture we found significantly lower Bhalla scores on HRCT scans of the lungs (11 +/- 3 versus 16 3, p